New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Fat » World Business Outlook
Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, recently announced the publication…
OmniActive’s Capsimax may work as a GLP-1 ‘booster’
In a randomized clinical study recently published in the Academic Journal of Sports Science & Medicine, scientists from…
Illumina’s constellation tech a star in Genedx pilot
Genedx LLC partnered with Illumina Inc. to test whether Illumina’s constellation map read technology could shed light on…
Pacbio’s Puretarget simplifies carrier screening
Up to 71% of people carry at least one pathogenic variant that could contribute to development of a…
‘Therapy speak’ misuses mental health terms, experts warn
CHARLESTON, S.C. (WCSC) – You may have heard a friend say they’re “so OCD” or call an ex…
Baylor Genetics to Showcase the Expanding Role and Clinical Value of Genetic Testing in Pediatric Neurology at the 2025 Child Neurology Society Annual Meeting
Company will feature new data on genomic diagnosis in epilepsy, advocate for expanded testing access, and host a…
Wegovy pill could deliver as much weight loss as the shot, trial shows
Eli Lilly and Novo Nordisk are vying for supremacy in the weight-loss market they dominate as they both…
MHRA approves UK’s ‘first new’ UTI antibiotic in 30 years
MHRA approves UK’s ‘first new’ UTI antibiotic in 30 years Home29 Aug 2025 • By Darcy Jimenez Trials found gepotidacin…
Biobank analysis suggests genetic links to side effects in antidepressants Labmate Online
Researchers at the University of Tartu Institute of Genomics have reported on the insights they discovered into why…